investor losses

Law Offices of Howard G. Smith filed securities fraud class actions against $CHOW, $GO, $ALIT, $IT, alleging false statements on operations and finances. Investors must file lead plaintiff motions by mid-May 2026.

Class action lawsuit alleges $PINS made false statements about advertising revenue declines and downplayed tariff impacts on business.

Schall Law Firm recruits investors for class action against Atara Biotherapeutics over alleged securities fraud involving tabelecleucel drug and ALLELE study claims, covering May 2024-January 2026 purchases.

Portnoy Law Firm investigates Beta Bionics for possible securities fraud after stock plummets 37% on disappointing Q4 2025 results showing user acquisition growth halved to 36%.

REGENXBIO faces class action lawsuit after FDA halted RGX-111 gene therapy trial due to CNS tumor, triggering 18% stock decline.

Portnoy Law Firm sues PayPal on behalf of investors, alleging management misled shareholders on revenue and growth targets before February earnings miss.

Portnoy Law Firm launches class action against $SLNO for allegedly concealing safety issues with lead drug DCCR, citing 27% stock plunge following patient death disclosure.

Schall Law Firm files class action against $GEMI for alleged securities fraud involving misrepresented crypto platform viability and overstated expansion prospects.

$GSIT shares fell 14.2% after legal investigation into allegedly misleading AI chip capability claims. Class action lawsuits being prepared to recover shareholder losses.

Corcept Therapeutics faces class action lawsuit for allegedly misleading investors about relacorilant's FDA prospects. Stock plummeted 50.4% after FDA rejection; investors from October 2024-December 2025 eligible to sue.

Rosen Law Firm investigates zSpace Inc. ($ZSPC) for allegedly misleading investor disclosures, preparing class action lawsuit seeking shareholder recovery.

Hub Group ($HUBG) revealed accounting errors in Q1-Q3 2025 results, requiring restatement. Stock fell 18.3% after disclosure; law firm investigating shareholder claims.

Rosen Law Firm urges $FBRT investors with $100K+ losses to secure counsel before April 27, 2026 lead plaintiff deadline in securities class action alleging false dividend sustainability claims.

Navan's stock has plummeted 64% from its $25 IPO price to $9.01 as a class action lawsuit alleges misleading IPO disclosures regarding sales and marketing expenses. Investors must act by April 24, 2026.

Rosen Law Firm investigates SYLA Technologies ($SYT) for allegedly misleading shareholders. Class action lawsuits seek investor compensation for losses.

PayPal faces securities class action over alleged misstatements on 2027 targets and product growth. Investors with $100K+ losses must act before April 20, 2026 deadline.

ODDITY Tech ($ODD) faces securities fraud lawsuit alleging failure to disclose algorithm changes by major ad partner that inflated customer acquisition costs and misled investors.

Securities lawsuit alleges NuScale Power made false statements about commercialization partner ENTRA1 Energy. Investors with $100K+ losses have until April 20, 2026 deadline.

monday.com faces securities fraud lawsuit after abruptly withdrawing $1.8B revenue target five months post-projection, sparking 21% stock collapse.

Coty Inc. faces securities fraud lawsuit alleging misleading growth guidance before 22% stock plunge. Law firm seeks class action damages.